Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

165,653 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tubeless video-assisted thoracic surgery for lung cancer: is it ready for prime time?
Wen Y, Jiang Y, Liang H, Jiang L, Guo Z, Musonza C, Thomas RL 3rd, Yang C, He J, Shen J, Chen L, Sun H, Wright GM, Zhang J, Yang Q, Zhong S, Liang W, Li S, Zhang J, He J. Wen Y, et al. Among authors: zhang j. Future Oncol. 2020 Jun;16(18):1229-1234. doi: 10.2217/fon-2020-0278. Epub 2020 May 7. Future Oncol. 2020. PMID: 32379503 No abstract available.
Endpoint surrogacy in oncology Phase 3 randomised controlled trials.
Zhang J, Pilar MR, Wang X, Liu J, Pang H, Brownson RC, Colditz GA, Liang W, He J. Zhang J, et al. Br J Cancer. 2020 Aug;123(3):333-334. doi: 10.1038/s41416-020-0896-5. Epub 2020 May 26. Br J Cancer. 2020. PMID: 32451466 Free PMC article.
Characteristics of toxicity occurrence patterns in concurrent chemoradiotherapy after induction chemotherapy for patients with locally advanced non-small cell lung cancer: a pooled analysis based on individual patient data of CALGB/Alliance trials.
Yang LZ, He Q, Zhang J, Ganti AK, Stinchcombe TE, Pang H, Wang X. Yang LZ, et al. Among authors: zhang j. Transl Cancer Res. 2022 Oct;11(10):3506-3521. doi: 10.21037/tcr-22-2006. Transl Cancer Res. 2022. PMID: 36388041 Free PMC article.
Comparison of first-generation EGFR-TKIs (gefitinib, erlotinib, and icotinib) as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutations.
He Q, Liu J, Cai X, He M, Li C, Liang H, Cheng B, Xia X, Guo M, Liang P, Zhong R, Li F, Yu Z, Zhao Y, Ou L, Xiong S, Li J, Zhang J, He J, Liang W. He Q, et al. Among authors: zhang j. Transl Lung Cancer Res. 2021 Nov;10(11):4120-4129. doi: 10.21037/tlcr-21-649. Transl Lung Cancer Res. 2021. PMID: 35004243 Free PMC article.
165,653 results
You have reached the last available page of results. Please see the User Guide for more information.